GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $87,000 | +1.2% | 2,004 | +1.2% | 0.02% | +15.0% |
| Q1 2022 | $86,000 | -5.5% | 1,980 | -4.5% | 0.02% | -4.8% |
| Q4 2021 | $91,000 | +237.0% | 2,074 | +185.7% | 0.02% | +200.0% |
| Q3 2021 | $27,000 | -3.6% | 726 | +0.8% | 0.01% | 0.0% |
| Q2 2021 | $28,000 | +12.0% | 720 | +1.0% | 0.01% | 0.0% |
| Q1 2021 | $25,000 | -3.8% | 713 | -0.6% | 0.01% | -12.5% |
| Q4 2020 | $26,000 | 0.0% | 717 | +2.3% | 0.01% | -11.1% |
| Q3 2020 | $26,000 | -7.1% | 701 | +0.7% | 0.01% | -18.2% |
| Q2 2020 | $28,000 | +12.0% | 696 | +1.0% | 0.01% | -8.3% |
| Q1 2020 | $25,000 | +25.0% | 689 | +61.4% | 0.01% | +71.4% |
| Q4 2019 | $20,000 | -53.5% | 427 | -58.2% | 0.01% | -56.2% |
| Q3 2019 | $43,000 | +168.8% | 1,022 | +144.5% | 0.02% | +166.7% |
| Q2 2019 | $16,000 | – | 418 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |